Cambridge Bioscience is pleased to announce that we have partnered with BioSkryb Genomics, a biotechnology company specializing in single-cell genomic analysis.
BioSkryb Genomics is renowned for its innovative genomic amplification technology, which enables high-resolution analysis of single-cell DNA. Their proprietary technology, Primary Template-directed Amplification (PTA), allows researchers to achieve unparalleled accuracy and completeness in detecting genetic variations at the single-cell level. This breakthrough has significant implications for applications such as cancer research, genetic disease diagnostics, and developmental biology.
The partnership will see Cambridge Bioscience distribute BioSkryb’s products across the UK, further expanding access to these tools for researchers in academic and clinical settings.
Learn more about BioSkryb or contact our BioSkryb specialists.